Investment archive

Investment feed — page 109

Back to latest investments

CREW Carbon — $6M grants and other non-dilutive capital

CREW Carbon — $6M grants and other non-dilutive capital

Aggregate non-dilutive component of the May2026 package; not equity and not entirely identified as grants. Full source-by-source split undisclosed.

CREW Carbon — $19M equity

CREW Carbon — $19M equity

Company announces $25M package comprising $19M equity plus $6M non-dilutive sources; only equity is recorded here.

DesignVerse raises $5.5M seed co-led by Begin Capital

DesignVerse raises $5.5M seed co-led by Begin Capital

DesignVerse announced a $5.5M seed co-led by Begin Capital and Gapminder VC, with Underline Ventures and strategic angels participating. Separate older pre-seed disclosed as $850K.

Mind Robotics raises $400M follow-on funding at reported $3.4B valuation

Mind Robotics raises $400M follow-on funding at reported $3.4B valuation

Mind Robotics announced an additional $400M led by Kleiner Perkins in May 2026, following a $500M March Series A and $115M seed in 2025. Reuters reported $3.4B valuation; company disclosed the financing but did not announce the valuation in its own release.

Fervo Energy celebrates Nasdaq IPO

Fervo Energy celebrates Nasdaq IPO

DCVC's May 13 announcement describes that morning's Nasdaq opening bell for Fervo's IPO under FRVO. DCVC first invested in 2022; the source does not disclose IPO proceeds or DCVC sales.

Recursive discloses $650M funding at $4.65B valuation

Recursive discloses $650M funding at $4.65B valuation

Recursive Superintelligence’s financing became public on May 13, 2026. Co-lead GV states $650M of funding at a $4.65B valuation. GV and Greycroft led the round, with Amplify among the investors.

Anduril announces $5B Series H co-led by Thrive and a16z

Anduril announces $5B Series H co-led by Thrive and a16z

Anduril announced a $5B Series H at a $61B valuation, jointly led by Thrive Capital and Andreessen Horowitz. Individual investor allocations were undisclosed.

Isomorphic Labs raises $2.1B Series B led by Thrive Capital

Isomorphic Labs raises $2.1B Series B led by Thrive Capital

AI drug design and development company funding for IsoDDE and drug pipeline; valuation undisclosed.

Photonic final close exceeds US$200M at US$2B post-money valuation

Photonic final close exceeds US$200M at US$2B post-money valuation

Photonic final close exceeds US$200M at US$2B post-money valuation